Year
2022
located
Hangzhou
TOTAL Site Area
>8’000 m²
Small & Pilot Scale GMP / non-GMP Development & manufacturing
With more than 10 years of experience in peptide development and production, the company’s scientific team is able to support a wide range of projects from early discovery to commercial production, with service scales ranging from mg to ton. Our peptide service platform has superior synthesis capabilities to support a wide variety of peptide types, including linear, cyclic, stapled and highly modified peptides, to meet the customized needs of different customers.
Through an innovative solid-liquid phase combination method, Yifan Biopharma can mass-produce high-purity, side-chain modified long chains and complex peptides, and has extensive practical experience in the field of complex peptide projects. In addition to core technical services, we also provide value-added services such as API analysis and CMC submission writing to fully help customers accelerate the market process of peptide drugs.
Our R&D capabilities at all stages of production
Laboratory scale
8 R&D lines;
Batch: 0.1-200 mmol (100 g per batch);
Annual output: 5-10 kg/ year
Pilot scale
2 production lines;
Batch: 200-1,500 mmol (2,000g per batch);
Annual output: 20-50 kg/year
Commercial scale
Annual production capability: >1.5 ton
Critical equipment
Laboratory scale equipment
SyroI parallel peptide synthesizer
Automatic purifier
Bottle freeze-drying machine
YMC (LAB100, FC500)
Freeze-drying machine (0.2㎡)
DAC system (DAC100)
Polit scale equipment
Semi-automatic peptide synthesizer (5L, 10L, 20L, 50L)
Semi-automatic peptide lysator 20L
Lysation-precipitation peptide reactor 100L
Film evaporation instrument
YMC (FC1500, K-PrepEX06KG-HPW)
DAC system (DAC150, DAC300, DAC450)
200mm spring column
Freeze-drying machine (0.5㎡, 1㎡, 5㎡)